Fluoxetine: all 159 studies that test it
Page 2 of 2. Open to participants first (18), then studies with results posted, then the rest; newest registration first within each.
- RCT of a Neuroplasticity Agent and CI Therapy for Severe Arm Paresis After StrokeWithdrawnNCT01963832Phase 2
- MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation TrialCompletedNCT01910259Phase 2
- Comparison of Venlafaxine and Fluoxetine in the Treatment of Postmenopausal Women With Major DepressionCompletedNCT01824433Phase 4
- Fluoxetine for Motor Recovery After Acute Intracerebral HemorrhageTerminatedNCT01737541Phase 3
- Role of Inflammation Factors and Insulin Resistance in Major Depressive DisorderStatus unknownNCT01699490Phase 4
- Fluoxetine for Motor, Aphasia, and Neglect Recovery After Ischemic StrokeWithdrawnNCT01674868Not applicable
- Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus (DM)CompletedNCT01672255Early Phase 1
- Fluoxetine Prevention TrialWithdrawnNCT01615055Early Phase 1
- Neurophysiologic Monitoring of Antidepressant TreatmentCompletedNCT01360190Phase 4
- Comparing Omeprazole With Fluoxetine for Treatment of Non Erosive Reflux Disease and Its Subgroups: a Double-blind Placebo-controlled Clinical TrialCompletedNCT01269788Phase 2/3
- Pharmacogenomics Studies of AntidepressantsStatus unknownNCT01204086Phase 4
- Biomarkers of Antidepressant Treatment in Adolescents With Major Depression (The Adolescents MDD Study)CompletedNCT01185977Phase 4
- Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules, 90 mg of Dr. Reddy's Under Fasting ConditionCompletedNCT01166100Phase 1
- Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules 90 mg of Dr. Reddy's Under Fed ConditionCompletedNCT01166087Phase 1
- Developing Adaptive Treatment Strategies for Children and Adolescents With Obsessive-compulsive Disorder.CompletedNCT01148316Not applicable
- Fluoxetine in Multiple System Atrophy PatientsCompletedNCT01146548Phase 2
- Effect of Curcumin as Nutraceutical in Patients of DepressionCompletedNCT01022632Not applicable
- Light, Ion, and Fluoxetine Efficacy (LIFE) in DepressionCompletedNCT00958204Phase 3
- To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Healthy Adult Males Under Fasting ConditionsCompletedNCT00913718Phase 1
- To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Healthy Adult Males Under Fed and Fasted ConditionsCompletedNCT00913588Phase 1
- Fluoxetine Essay in Children With AutismWithdrawnNCT00873834Phase 2
- Extended Management and Measurement of AutismTerminatedNCT00787111Phase 3
- Bioequivalence Study of Fluoxetine HCL 40 mg Capsules Under Fasting ConditionsCompletedNCT00778024Not applicable
- Fluoxetine vs. Brief Psychotherapy for Major DepressionCompletedNCT00714779Not applicable
- Fluoxetine on Motor Rehabilitation After Ischemic StrokeCompletedNCT00657163Phase 2
- Fasting Study of Fluoxetine Capsules 40 mg and Prozac Pulvules 40 mgCompletedNCT00649636Phase 1
- Predictors of Treatment Response to Fluoxetine in PTSD Following a Recent History of War Zone Stress ExposureStatus unknownNCT00633685Phase 4
- Hypoglycemia Associated Autonomic Failure in Type 1 DMCompletedNCT00592670Not applicable
- Open Label Trial of Fluoxetine for the Treatment of Depression in Patients With End Stage Renal DiseaseWithdrawnNCT00573547Phase 4
- Study of Fluoxetine in AutismCompletedNCT00515320Phase 3
- Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I DepressionCompletedNCT00485771Phase 4
- Prozac Treatment of Major Depression: Discontinuation StudyCompletedNCT00427128Phase 4
- Antidepressant Medication Plus Directly Observed Therapy for Improving Adherence to Antiretroviral TherapyCompletedNCT00338767Phase 2
- Determining Optimal Continuation Treatment Duration for Depressed Children and AdolescentsCompletedNCT00332787Not applicable
- Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research GroupCompletedNCT00265291Phase 2
- Maintenance Interpersonal Psychotherapy for Sustaining Remission of DepressionCompletedNCT00227981Not applicable
- Does Fluoxetine Have an Effect on the CNS CRF Systems in Women Abused in Childhood?CompletedNCT00208897Not applicable
- A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar DisorderCompletedNCT00188942Phase 4
- Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid AddictsCompletedNCT00142779Not applicable
- Fluoxetine as a Quit Smoking AID for Depression ProneCompletedNCT00113737Not applicable
- Determinants in Antidepressant OutcomesWithdrawnNCT00108316Not applicable
- Substance Dependent Teens - Impact of Treating Depression Study 1 - 1CompletedNCT00061113Phase 4
- Treatment of Childhood Social PhobiaCompletedNCT00043537Phase 3
- The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant DepressionCompletedNCT00035321Phase 3
- Study of Fluoxetine in Adults With Autistic DisorderCompletedNCT00027404Not applicable
- Treatment of SSRI-Resistant Depression In Adolescents (TORDIA)CompletedNCT00018902Phase 2/3
- Effect of Antidepressants on Back PainCompletedNCT00018200Phase 2
- Fluoxetine as a Quit Smoking Aid for Depression-Prone SmokersCompletedNCT00018174Phase 3
- Effect of Fluoxetine (Prozac) on Domestic ViolenceCompletedNCT00011765Phase 2
- Treatment of Bulimia Nervosa in a Primary Care SettingCompletedNCT00009178Not applicable
- Treatment for Adolescents With Depression Study (TADS)CompletedNCT00006286Phase 3
- Drug Treatment for Depressed Alcoholics (Naltrexone/Fluoxetine)CompletedNCT00006204Phase 4
- Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerCompletedNCT00005850Phase 2
- Treatment of Depression in Youth With Bipolar DisordersTerminatedNCT00005015Phase 3
- Randomized Study of Fluoxetine in Children and Adolescents With AutismCompletedNCT00004486Not applicable
- Study of Fluoxetine in Patients With Depersonalization DisorderCompletedNCT00004446Not applicable
- Fluoxetine for Anxious ChildrenCompletedNCT00000381Phase 3
- Fluoxetine vs EMDR to Treat Post-Traumatic Stress Disorder (PTSD)CompletedNCT00000379Phase 3
- IV Cocaine Abuse: A Laboratory Model - 2CompletedNCT00000213Phase 2